.png)
.png)
Tonia Poteat, PhD, MPH, PAC
Associate Professor
University of North Carolina School of Medicine, NC, United States
Disclosure: Disclosure(s): Merck & Co. Inc: Advisor/Consultant (Terminated); Viiv Healthcare: Advisor/Consultant (Ongoing)
Supriya Sarkar, PhD, MPH
Director, Epidemiology and Real World Evidence
ViiV Healthcare
Baltimore, Maryland, United States
Disclosure: Disclosure(s): ViiV Healthcare: Salary (), Stocks/Bonds ()
Leigh Ragone, MS
Strategy & Governance Director
ViiV Healthcare
RTP, North Carolina, United States
Disclosure: Disclosure(s): GlaxoSmithKline: Stocks/Bonds (); ViiV Healthcare: Employment ()
Keith Rawlings, MD
Senior Medical Director
ViiV Healthcare
Durham, North Carolina, United States
Disclosure: Disclosure(s): ViiV Healthcare: Employee ()
Alex R. Rinehart, PhD
Medicine Development Leader, Prevention
ViiV Healthcare
Durham, North Carolina, United States
Disclosure: Disclosure(s): ViiV Healthcare: Stocks/Bonds ()
Jennifer N. Hill, MA
Implementation Science Research Scientist
Evidera
Bethesda, Maryland, United States
Disclosure: Disclosure(s): No financial relationships to disclose
Kyli Gallington, MPH
Senior Research Associate
Evidera
Sacramento, California, United States
Disclosure: Disclosure(s): No financial relationships to disclose
Karin S. Coyne, PhD, MPH
Vice President
Evidera
Bethesda, Maryland, United States
Disclosure: Disclosure(s): No financial relationships to disclose
Vani Vannappagari, MBBS, MPH, PhD
Global Head, Epidemiology & Real World Evidence
ViiV Healthcare
Research Triangle Park, North Carolina, United States
Disclosure: Disclosure(s): ViiV Healthcare: I am full time employee of ViiV Healthcare and receive GlaxoSmithKline stock as part of my compensation package (), Stocks/Bonds ()